Condition

Chlamydia Trachomatis Infection

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common interventions8
Lead sponsors shown5
Advertisement

Clinical trials

5 shown
Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)NCT05581160 · 2022-07-11
COMPLETED
Integrating Enhanced HIV PrEP Into a STI Clinic in LilongweNCT05307991 · 2022-03-09
COMPLETED
Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South AfricaNCT06131749 · 2021-03-01
COMPLETED
GonoScreen: Efficacy of Screening STIs in MSMNCT04269434 · 2020-09-21
COMPLETED
Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEPNCT04050540 · 2020-02-05
COMPLETED

Trial status mix

COMPLETED5

Phase mix

NA2
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.